JC Platform – The "True Whole Blood" Chemiluminescence Solution

JC Pre Automated Sample Processing System

The revolutionary front-end solution that enables direct whole-blood testing on the CLIA platform.

JC 220 - Fully Automated CLIA Analyzers

Relevant reagents

Learn more about the reagent information related to this platform

Learn More

Platform Overview

The JOINSTAR Chemiluminescence Immunoassay (CLIA) Platform is engineered to deliver highly accurate quantitative diagnostics using the advanced direct chemiluminescence method based on acridinium ester. Our platform redefines laboratory efficiency by introducing an innovative "True Whole Blood" technology. By seamlessly integrating automated sample preparation with high-speed analyzers, we offer a comprehensive ecosystem for the early warning, diagnosis, and monitoring of cardiovascular diseases, infections, chronic conditions, and organ injuries.

Why Choose the JC Platform?

Pioneering "True Whole Blood" Innovation

Redefining laboratory workflow, the JC platform features our groundbreaking "True Whole Blood" testing technology, which officially launched in 2025. By seamlessly integrating automated sample preparation, it significantly reduces manual intervention and processing time.

Advanced Direct Chemiluminescence

Engineered for uncompromising precision, the platform utilizes the advanced direct chemiluminescence method based on acridinium ester. This ensures highly accurate, quantitative diagnostic results that clinicians can trust for critical decision-making.

Comprehensive Clinical Ecosystem

JoinStar provides a complete ecosystem for the early warning, diagnosis, and continuous monitoring of various conditions. Our extensive assay menu covers critical and emerging areas, including Cardiovascular Disease (CVD), Alzheimer's Disease (AD), Coagulation function, Tumor markers, and Thyroid function.

Fully Automated High-Speed Efficiency

Designed specifically for the demanding environments of modern central laboratories, the platform seamlessly combines automated processes with high-speed analyzers. This maximizes throughput and optimizes turnaround times for comprehensive disease management.

Key Advantages

"True Whole Blood" Technology

Features our innovative whole blood testing technology to significantly streamline laboratory workflows.

Comprehensive Assay Menu

Offers extensive clinical testing panels, prominently including Cardiovascular Disease (CVD), Alzheimer's Disease (AD), and Tumors.

Advanced CLIA System

Delivers highly accurate and efficient automated diagnostics through our cutting-edge CLIA system.